Literature DB >> 27538557

Epidemiological survey of hypertension in Anambra state, Nigeria.

C N Ezekwesili1, C J Ononamadu2, O F Onyeukwu1, N C Mefoh3.   

Abstract

BACKGROUND: Hypertension is a major public health problem worldwide. Estimating the prevalence of disease in populations of Nigeria would be useful in developing intervention programs to control it and prevent its consequences.
OBJECTIVE: This survey was carried out to assess the prevalence, awareness, treatment, detection and risk factors of hypertension in three major populations - Onitsha, Nnewi and Awka cities of Anambra State.
METHODS: The study was a church based cross sectional study involving 912 participants randomly selected from the three major zones in Anambra State. The age range of the participants was 17-79 years. Participants were administered with a well-structured questionnaire and their blood pressures (BP) as well as anthropometric measurements were taken using standard instruments.
RESULTS: The study population (n = 912) consists, 476 (52.16%) females and 436 (47.81%) males; sampled randomly from Awka, Onitsha and Nnewi. The overall crude prevalence of hypertension and prehypertension in the study population were 22.81% and 42.54% respectively. The crude prevalence of hypertension in the three cities - Onitsha, Awka and Nnewi were 32.56%, 19.665 and 16.40% respectively. The prevalence of hypertension was significantly higher in Onitsha (P = 0.0001). The prevalence of hypertension in both sexes was not statistically different (male, 22.01% and female, 23.5% P = 0.587). Mean BMI, Systolic, and Diastolic BP for the study population was 25.43 ± 4.2, 120.7 ± 18.39 and 78.21 ± 12.57 respectively. Systolic and diastolic BP correlated with age and anthropometric measures such as waist circumference, BMI, Hip circumference, weight and height. The following factors were strongly associated with the prevalence of hypertension in our study population: Age (χ2 = 110.87, P = 0.000); Zone (χ2 = 25.19, P = 0.000); BMI (χ2 = 45.51, P = 0.000); Physical Activity(χ2 = 58.08, P = 0.000); Alcohol Consumption (χ2 = 32.27, P = 0.000); Smoking (χ2 = 7.892, P = 0.000); General Health status (χ2 = 46,62, P= 0.000); Consumption of fatty food (χ2 = 29.35, P = 0.000). A low percentage of the population, 9.76% reported previous diagnosis of high BP and 34.59% of 910 of the participants also reported previous BP diagnosis of any relative. Our result shows that the prevalence of hypertension and prehypertension in this population was high and associated with some modifiable risk factors. In addition, poor detection, treatment and control of hypertension in this population were observed. This underscores the need for comprehensive evaluation of the prevalence of hypertension and other cardiovascular diseases in Nigeria.

Entities:  

Mesh:

Year:  2016        PMID: 27538557     DOI: 10.4103/1119-3077.188710

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  11 in total

1.  The Prevalence and Social Determinants of Hypertension among Adults in Indonesia: A Cross-Sectional Population-Based National Survey.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  Int J Hypertens       Date:  2018-08-09       Impact factor: 2.420

2.  Active smoking among people with diabetes mellitus or hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Jobert Richie Nansseu; Francky Teddy Endomba; Anderson Ngouo; Jan René Nkeck; Ulrich Flore Nyaga; Arnaud D Kaze; Jean Joel Bigna
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  The prevalence, awareness, treatment, and control of hypertension among adults: the first cross-sectional national population-based survey in Laos.

Authors:  Supa Pengpid; Manithong Vonglokham; Sengchanh Kounnavong; Vanphanom Sychareun; Karl Peltzer
Journal:  Vasc Health Risk Manag       Date:  2019-02-27

4.  Assessment of the level of knowledge, awareness and management of hypertension and diabetes among adults in Imo and Kaduna states, Nigeria: a cross-sectional study.

Authors:  Jennifer Anyanti; Selema Margaret Akuiyibo; Oluwole Fajemisin; Omokhudu Idogho; Babatunde Amoo
Journal:  BMJ Open       Date:  2021-03-08       Impact factor: 2.692

5.  Estimating the prevalence of overweight and obesity in Nigeria in 2020: a systematic review and meta-analysis.

Authors:  Davies Adeloye; Janet O Ige-Elegbede; Martinsixtus Ezejimofor; Eyitayo O Owolabi; Nnenna Ezeigwe; Chiamaka Omoyele; Rex G Mpazanje; Mary T Dewan; Emmanuel Agogo; Muktar A Gadanya; Wondimagegnehu Alemu; Michael O Harhay; Asa Auta; Akindele O Adebiyi
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 6.  Prevalence and Risks Factors of Prehypertension in Africa: A Systematic Review.

Authors:  Koussoh Simone Malik; Kassi Anicet Adoubi; Jérôme Kouame; Madikiny Coulibaly; Marie-Laure Tiade; Serge Oga; Michèle Ake; Odile Ake; Luc Kouadio
Journal:  Ann Glob Health       Date:  2022-03-01       Impact factor: 2.462

7.  Effects of behaviour change communication on hypertension and diabetes related knowledge, attitude and practices in Imo and Kaduna States: a quasi-experimental study.

Authors:  Selema Akuiyibo; Jennifer Anyanti; Babatunde Amoo; Dennis Aizobu; Omokhudu Idogho
Journal:  BMC Public Health       Date:  2022-04-11       Impact factor: 3.295

8.  Prevalence and correlates of prehypertension and hypertension among adults in Delta State, Nigeria: a cross-sectional community-based study.

Authors:  Ejiroghene M Umuerri; Henry O Aiwuyo
Journal:  Ghana Med J       Date:  2020-03

9.  Current prevalence pattern of tobacco smoking in Nigeria: a systematic review and meta-analysis.

Authors:  Davies Adeloye; Asa Auta; Ademola Fawibe; Muktar Gadanya; Nnenna Ezeigwe; Rex G Mpazanje; Mary T Dewan; Chiamaka Omoyele; Wondimagegnehu Alemu; Michael O Harhay; Isaac F Adewole
Journal:  BMC Public Health       Date:  2019-12-21       Impact factor: 3.295

10.  Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence.

Authors:  Davies Adeloye; Eyitayo O Owolabi; Dike B Ojji; Asa Auta; Mary T Dewan; Timothy O Olanrewaju; Okechukwu S Ogah; Chiamaka Omoyele; Nnenna Ezeigwe; Rex G Mpazanje; Muktar A Gadanya; Emmanuel Agogo; Wondimagegnehu Alemu; Akindele O Adebiyi; Michael O Harhay
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.